HealthQuill Drugs
Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood cancer therapy.
Drugs Health Pharma

J&J seeks approval for its blood cancer therapy in US, European Union

Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood.

Read More
US farm workers exposed to bird flu who do not show symptoms and do not wear personal protection equipment should be tested for the virus, according to the nation’s national public health agency.
Drugs Health Pharma

US public health agency updates bird flu guidance for farm workers 

US farm workers exposed to bird flu who do not show symptoms and do not wear personal protection equipment should be tested for.

Read More
The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a new target date set for March next year.
Drugs Health Pharma

USFDA postpones Organon’s eczema drug review by three months

The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a.

Read More
Malaria, HIV, and tuberculosis were among a list of 17 disease-causing pathogens where vaccines need to be developed as a priority to reduce regional disease burden, according to the World Health Organization.
Drugs Health Pharma

Malaria, TB among top diseases where vaccines needed most: WHO 

Malaria, HIV, and tuberculosis were among a list of 17 disease-causing pathogens where vaccines need to be developed as a priority to reduce.

Read More
An illustration of a pair of lungs that are filled with various circles of different colour and size. Some smaller circles are floating outside of the lungs. Image Credit: National Health Service. Metagenomic testing for diagnosis and surveillance
Drugs Health Pharma

UK consortium to build world’s first real-time pandemic surveillance system

The UK, along with a clutch of government and private entities, has set afoot plans to create the world’s first real-time surveillance system.

Read More
Britain has detected two cases of Clade Ib mpox, a variant, in household contacts of the first case, taking the total to three since last week, according to the UK Health Security Agency (UKSHA).
Drugs Health Pharma

Britain detects two more cases of mpox variant, risk ‘remains low’

Britain has detected two cases of Clade Ib mpox, a variant, in household contacts of the first case, taking the total to three.

Read More
The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability of a rectal microbicide douche containing the antiretroviral drug tenofovir to prevent HIV infection spread among men.
Drugs Health Pharma

Mid-stage trial of a rectal microbicide for HIV prevention in the US begins 

HQ Team November 3, 2024: The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability.

Read More
The EU faces a new set of healthcare challenges potentially more potent than the Covid-19 pandemic, and some states are “miles away” from ensuring efficient preventive environments, according to a report from the independent Globsec.
Drugs Health Pharma

EU faces new healthcare threats, some states ‘miles away’ from ready 

The EU faces a new set of healthcare challenges potentially more potent than the Covid-19 pandemic, and some states are “miles away” from.

Read More
Danish multinational pharmaceutical company Novo Nordisk’s end-stage trial in patients with fatty liver disease saw reduced liver scarring (fibrosis) and its resolution without worsening the condition.
Drugs Health Pharma

Novo Nordisk’s weight loss drug reduces liver scarring in end-stage trial

Danish multinational pharmaceutical company Novo Nordisk’s end-stage trial in patients with fatty liver disease saw reduced liver scarring (fibrosis) and its resolution without.

Read More
GSK Plc will pay China’s privately-held Chimagen Biosciences $300 million upfront to develop and commercialise a T-cell engager to treat autoimmune diseases.
Drugs Health Medical

GSK to pay Chimagen $300m upfront to develop autoimmune drug 

GSK Plc., will pay China’s privately-held Chimagen Biosciences $300 million upfront to develop and commercialise a T-cell engager to treat autoimmune diseases.

Read More